Veradermics MANE Interest Expense
Interest Expense at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Veradermics ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's interest expense?
- Veradermics (MANE) reported interest expense of $0 in Q4 2025.
- How has Veradermics 's interest expense changed year-over-year?
- Veradermics 's interest expense decreased by 100.0% year-over-year, from $146.25K to $0.
- What does interest expense mean?
- The cost of borrowing money.
- How do you interpret interest expense?
- Higher interest expense indicates increased leverage and potential financial risk, while lower expense suggests a stronger balance sheet or lower debt levels.
- How does interest expense compare across companies?
- Biotech firms often have low interest expense if they rely primarily on equity financing rather than debt.